AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Up 2.2% – What’s Next?

Posted by Defense World Staff on Nov 27th, 2025

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report) shares were up 2.2% on Wednesday . The stock traded as high as $18.48 and last traded at $18.45. Approximately 3,248 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 13,539 shares. The stock had previously closed at $18.06.

AdvisorShares Psychedelics ETF Trading Up 2.2%

The firm’s fifty day moving average price is $19.00 and its two-hundred day moving average price is $16.59.

AdvisorShares Psychedelics ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 29th. Investors of record on Monday, September 22nd were paid a dividend of $0.0201 per share. This represents a $0.08 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Monday, September 22nd.

Institutional Investors Weigh In On AdvisorShares Psychedelics ETF

A hedge fund recently bought a new stake in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. bought a new position in AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) during the third quarter, according to its most recent filing with the SEC. The firm bought 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned approximately 2.50% of AdvisorShares Psychedelics ETF as of its most recent SEC filing.

About AdvisorShares Psychedelics ETF

(Get Free Report)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.